Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia ; day:16 ; month:12 ; year:2024 ; pages:1-13
Leukemia ; (16.12.2024), 1-13

Creator
Balestra, Tommaso
Niswander, Lisa M.
Bagashev, Asen
Loftus, Joseph P.
Ross, Savannah L.
Chen, Robert K.
McClellan, Samantha M.
Junco, Jacob J.
Bárcenas López, Diego A.
Rabin, Karen R.
Fry, Terry J.
Tasian, Sarah K.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41375-024-02493-3
URN
urn:nbn:de:101:1-2502272219057.013276931109
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Balestra, Tommaso
  • Niswander, Lisa M.
  • Bagashev, Asen
  • Loftus, Joseph P.
  • Ross, Savannah L.
  • Chen, Robert K.
  • McClellan, Samantha M.
  • Junco, Jacob J.
  • Bárcenas López, Diego A.
  • Rabin, Karen R.
  • Fry, Terry J.
  • Tasian, Sarah K.
  • SpringerLink (Online service)

Other Objects (12)

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes

Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes

Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia

Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia

Premature thymic functional senescence is a hallmark of childhood acute lymphoblastic leukemia survivorship

Premature thymic functional senescence is a hallmark of childhood acute lymphoblastic leukemia survivorship

Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia

Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia

Selective involution of thymic medulla by cyclosporine A with a decrease of mature thymic epithelia, XCR1+ dendritic cells, and epithelium-free areas containing Foxp3+ thymic regulatory T cells

Selective involution of thymic medulla by cyclosporine A with a decrease of mature thymic epithelia, XCR1+ dendritic cells, and epithelium-free areas containing Foxp3+ thymic regulatory T cells

Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia

Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia

Rearranged Stochastic Heat Equation

Rearranged Stochastic Heat Equation

Naturally Occurring Rearranged Taxoids1,*

Naturally Occurring Rearranged Taxoids1,*

Thymic tumors

Konferenzschrift | Kongress

Thymic tumors

Thymic hormones

Thymic hormones

Related objects